BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25205302)

  • 1. Coupling of prostate and thyroid cancer diagnoses in the United States.
    Tomaszewski JJ; Uzzo RG; Egleston B; Corcoran AT; Mehrazin R; Geynisman DM; Ridge JA; Veloski C; Kocher N; Smaldone MC; Kutikov A
    Ann Surg Oncol; 2015 Mar; 22(3):1043-9. PubMed ID: 25205302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.
    Lal G; Groff M; Howe JR; Weigel RJ; Sugg SL; Lynch CF
    Ann Surg Oncol; 2012 Jun; 19(6):1887-96. PubMed ID: 22227921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
    Abhyankar N; Hoskins KF; Abern MR; Calip GS
    BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis.
    Banner L; Rohan TZ; Zachian R; Gross T; Yang HY; Joffe D; Porcu P; Nikbakht N
    J Am Acad Dermatol; 2024 Jul; 91(1):151-153. PubMed ID: 38513830
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
    Pawlish KS; Schottenfeld D; Severson R; Montie JE
    Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Second Primary Malignancies After External Beam Radiotherapy for Thyroid Cancer.
    Jin MC; Qian ZJ; Megwalu UC
    Anticancer Res; 2022 Mar; 42(3):1359-1365. PubMed ID: 35220228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second malignancies among survivors of pediatric thyroid cancer.
    Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
    Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
    Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
    Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
    Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation Therapy Changed the Second Malignancy Pattern in Rectal Cancer Survivors.
    Ye X; Tan Y; Ma R; Lou P; Yuan Y
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629753
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.
    Davis EJ; Beebe-Dimmer JL; Yee CL; Cooney KA
    Cancer; 2014 Sep; 120(17):2735-41. PubMed ID: 24842808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database.
    Anderson JK; Alanee S; Lindgren B; Slaton J
    Urol Oncol; 2013 Aug; 31(6):862-5. PubMed ID: 21784673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
    Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L
    Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple primary tumors involving cancer of the brain and central nervous system as the first or subsequent cancer.
    Inskip PD
    Cancer; 2003 Aug; 98(3):562-70. PubMed ID: 12879474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.